It is a pharma private limited company based in Godhra, Gujarat, India, established in 1996.
1996 | Godhra, Gujarat, India | ActiveZibran Pharmaceuticals Private Limited, a active private limited company, was established on 17 June 1996 in Godhra, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231GJ1996PTC029956. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Its leadership includes Kanaiyalal Shomeshwar Joshi (Director), Rameshbhai Somabhai Patel (Director). Past directors included Kanaiyalal Shomeshwar Joshi, Samunbhai Kikabhai Kharkhariwala, Somabhai Laldas Patel. It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101, Gidc, Industrial Estate,, Godhra, Gujarat, 389001.
U24231GJ1996PTC029956
029956
17 June 1996
₹4.00 M
₹4.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Zibran Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanaiyalal Shomeshwar Joshi | Director | 29 Apr 2019 | Current |
| Rameshbhai Somabhai Patel | Director | 30 Nov 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 12 Jul 2022 | Past |
| Pramod Abcsdd | Director | 07 May 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zibran Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 60.2% increase. The company also saw a substantial improvement in profitability, with a 67.78% increase in profit. The company's net worth moved up by a moderate rise of 5.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Zibran Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹14,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2019 | Others | ₹1.50 M | Open |
| 23 Jan 2012 | Bank Of Baroda (Bob) | ₹1.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Zibran Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zibran Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zibran Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Zibran Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Zibran Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on A charge with Others of Rs. 1.50 M registered on 09 Dec 2019 with Charge ID 100307186 was modified on 16 Jan 2020. was documented.
The activity A charge with Others amounted to Rs. 1.50 M with Charge ID 100307186 was registered on 09 Dec 2019. was completed.
Kanaiyalal Shomeshwar Joshi was appointed as a Director was appointed as a Director on 29 Apr 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
A charge with Bank Of Baroda (Bob) amounted to Rs. 12.50 M with Charge ID 10335907 was registered on 23 Jan 2012. was recorded as a recent event.
The CIN of Zibran Pharmaceuticals Private Limited is U24231GJ1996PTC029956.
Zibran Pharmaceuticals Private Limited is headquartered at 101, Gidc, Industrial Estate,, Godhra, Gujarat, 389001.
Zibran Pharmaceuticals Private Limited was incorporated on 17 June 1996.
The current directors of Zibran Pharmaceuticals Private Limited are
The primary industry of Zibran Pharmaceuticals Private Limited is Pharma.
Zibran Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zibran Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Zibran Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX